COMMUNIQUÉS West-GlobeNewswire

Nexstim Oyj: EUR 5.2 million rights issue Of Nexstim Oyj
26/03/2019
Company announcement, Helsinki, 26 March 2019 klo 15.20 Nexstim Oyj: EUR 5.2 million rights issue Of Nexstim Oyj NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO THE UNITED STATES OF AMERICA, CANADA, NEW [...]
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
26/03/2019
Company Announcement sBLA submitted to U.S. FDA for daratumumab in combination with bortezomib, thalidomide and dexamethasone as treatment for newly diagnosed patients with multiple myeloma who are candidates for [...]
Lundbeck held its Annual General Meeting on 26 March 2019 at the company’s registered office
26/03/2019
Valby, Denmark, 26 March 2019 - H. Lundbeck A/S (Lundbeck) announced today that the report by the Board of Directors was adopted and the annual report was approved at the annual general meeting. The proposal to [...]
CareDx Files Patent Infringement Lawsuit Against Natera
26/03/2019
CareDx protects innovation in transplantation by enforcing patent protection BRISBANE, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the [...]
FemPulse to Participate in Panel Discussion at the 2019 Bioelectronic Medicine Forum
26/03/2019
Don Deyo, President & CEO, to present novel bioelectronic solution for women with OAB during the Entrepreneur Panel I session [at 10:15am ET on Thursday, April 4th] MINNEAPOLIS, March 26, 2019 (GLOBE NEWSWIRE) -- [...]
Biodesix Previews Data for Osimertinib Resistance and Precision of Liquid Biopsy at AACR
26/03/2019
New Data to be Presented at American Association for Cancer Research Annual Meeting BOULDER, Colo., March 26, 2019 (GLOBE NEWSWIRE) -- Biodesix ® will release new data demonstrating the potential diagnostic utility of a [...]
Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting
26/03/2019
Excellagen Clinical Trial Analysis: Rapid Healing of Diabetic Neuropathic Foot Ulcers Presentation on Friday Evening April 5, 2019 at the JW Marriott Hotel in Washington, DC MIRAMAR, FL, March 26, 2019 (GLOBE NEWSWIRE [...]
OpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock
26/03/2019
GAITHERSBURG, Md., March 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today the pricing of an underwritten public offering of 9 million shares of its common stock at a public offering price of $0. [...]
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
26/03/2019
Jeff Elliott adds relevant experience to Exagen’s Board of Directors as a former diagnostics analyst at Robert W. Baird & Co. as well as the current CFO of Exact Sciences San Diego, CA and Albuquerque, NM, March 26 [...]
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Featured in NetworkNewsWire Publication on Soaring Hemp-Based CBD Industry
26/03/2019
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Wildflower Brands [...]
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
26/03/2019
LAVAL, Quebec, March 26, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children
26/03/2019
First Latin American Approval of Crysvita, the only Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease NOVATO, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc [...]
Scilex Holding, a Subsidiary of Sorrento Therapeutics, Announces Phase 2 Trial Results for its Leading SP-102 Program
26/03/2019
Complete Enrollment of Phase 2 Trial to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 Administered by Epidural Injection in Subjects with Lumbosacral Radiculopathy, a.k.a. sciatica All subjects [...]
Agritek Holdings, Inc. Announces Proposed Purchase Agreement for Licensed Cannabis Cultivation and Manufacturing Facility in San Juan, Puerto Rico
26/03/2019
LOS ANGELES, CA, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTCQB: AGTKD) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]
Protech Home Medical Announces Redemption of 7.5% Non-Convertible Unsecured Subordinated Debentures
26/03/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Ohio, March 26, 2019 (GLOBE NEWSWIRE) -- Protech [...]
Vectura Group plc 2018 Preliminary Results
26/03/2019
This contains inside information 2018 Preliminary Results - Vectura reports strong 2018 financial and operational performance - Chippenham, UK – 26 March 2019 : Vectura Group plc (LSE: VEC) ("Vectura" or "the Group") [...]
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical Officer
26/03/2019
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical Officer Gosselies, Belgium and Cambridge, MA – March 26, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel [...]
Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia
26/03/2019
Oxford Biomedica notes the Japanese approval of Kymriah ® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia Oxford, UK – 26 March 2019: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy [...]
Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility
26/03/2019
EAST RUTHERFORD, N.J., March 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]

Pages